Our study aim was to investigate the complete wound-healing rate in patients with chronic limb-threatening ischemia after endovascular revascularization, comparing the effectiveness of wound care management by plastic surgeons with other medical specialists.
Board Certified Plastic Surgeon Earl M. Johnson, Jr, comments on a study by Fujihara et al, who evaluate the current impact of plastic surgeons in managing wounds for patients with CLTI.
We performed a meta-analysis of randomized controlled trials investigating the clinical outcomes of patients undergoing percutaneous revascularization with DCB vs percutaneous transluminal angioplasty (PTA) of infrapopliteal arteries.
Dr Zeller comments on a recent JCLI meta-analysis by Al Halabi et al, who examined paclitaxel-coated drug-coated balloon (DCB) angioplasty in infrapopliteal artery lesions and found significant benefits for the use of DCB.
This study investigates the cost-effectiveness of bypass surgery vs endovascular intervention in CLTI with femoropopliteal lesions.
The recently published JCLI study by Perlander and colleagues offers an opportunity to focus on the existing gaps in our understanding of cost-effectiveness in the care for CLTI patients.